Erythropoiesis-stimulating agents (ESA) are medications which stimulate the bone marrow to make red blood cells. They are used to treat anemia due to end stage kidney disease, chemotherapy, major surgery, or certain treatments in HIV/AIDS.
This report contains market size and forecasts of Erythropoietin Stimulating Agents in Global, including the following market information:
Global Erythropoietin Stimulating Agents Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Erythropoietin Stimulating Agents market was valued at 6111 million in 2021 and is projected to reach US$ 6663.4 million by 2028, at a CAGR of 1.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Epoetin Alfa Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Erythropoietin Stimulating Agents include Pfizer, Amgen, BioSidus, Biocon, Celltrion, Roche, Intas Pharmaceuticals, Johnson and Johnson and Teva Pharmaceutical Industries and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erythropoietin Stimulating Agents companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erythropoietin Stimulating Agents Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Erythropoietin Stimulating Agents Market Segment Percentages, by Type, 2021 (%)
Epoetin Alfa
Epoetin Beta
Darbepoetin Alfa
Others
Global Erythropoietin Stimulating Agents Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Erythropoietin Stimulating Agents Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Erythropoietin Stimulating Agents Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Erythropoietin Stimulating Agents Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erythropoietin Stimulating Agents revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Erythropoietin Stimulating Agents revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Amgen
BioSidus
Biocon
Celltrion
Roche
Intas Pharmaceuticals
Johnson and Johnson
Teva Pharmaceutical Industries
Thermo Fisher Scientific